To characterize the relationship between computed tomography angiography (CTA) imaging characteristics of carotid artery and the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) score. METHODS: We retrospectively identified all patients who underwent a cervical CTA at our institution from January 2013 to July 2016, extracted clinical information, and calculated the 10-year ASCVD score using the Pooled Cohort Equations from the 2013 ACC/AHA guidelines. We compared the imaging features of artery atherosclerosis derived from the CTAs between low and high risk.
Introduction
The Pooled Cohort Equations 1 formula includes age, sex, race, blood pressure, cholesterol values, diabetes mellitus, and smoking status, and is used to estimate atherosclerotic cardiovascular disease (ASCVD) risk. In November 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) released new recommendations to guide initiation of statin treatment for the primary prevention of ASCVD. 2 These guidelines were a departure from previous recommendations. 3 The ACC/AHA guidelines established four categories for at least moderate-intensity statin treatment eligibility for adults aged 40-75 years, including 10-year AS-CVD risk score of 7.5% or higher.
Under the previous ACC/AHA guidelines using history of cardiovascular disease or diabetes or elevated low density lipoprotein (LDL) cholesterol, an estimated 8-17% of adults were eligible for statins. 4 With the more recent recommended ASCVD risk score threshold of 7.5% or higher, an estimated 28-48% of adults would now be eligible for statin treatment. [5] [6] [7] The expansion of statin treatment eligibility under ACC/AHA guidelines has been controversial. [8] [9] [10] Although statins are generally well tolerated, they have side effects, including myalgias, and are associated with a small but significant increased risk of incident type 2 diabetes.
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Vascular imaging is not part of the main 2013 ACC/AHA guidelines, although a coronary artery calcium (CAC) score of ࣙ300 Agatston units or ࣙ75th percentile for age, sex, and ethnicity is mentioned as a specific risk factor in individuals for whom risk assessment is uncertain. 2 Vascular imaging could potentially be performed in more general populations to identify asymptomatic individuals at particularly high risk for cardiac and cerebrovascular events or identify patients with high ASCVD risk scores but low-risk imaging characteristics. In contrast to some circulating biomarkers and all genetic biomarkers, imaging tests detect existing disease, typically signs of atherosclerosis, and might have the advantage of improved predictive accuracy, particularly in the short-tomedium term, because individuals with subclinical disease may be closer to having overt clinical events compared with those who simply have a predisposition for disease. On the other hand, the likelihood of plaque rupture is not necessarily correlated with the size of the plaque or other imaging characteristics. The most widely studied imaging tests of subclinical atherosclerosis are coronary calcium scanning, carotid ultrasound, or computed tomography angiography (CTA).
In this study, we want to determine whether patients with a higher 10-year ASCVD risk score have more advanced imaging features of carotid artery atherosclerosis. For this purpose, we analyzed the relationship between CTA imaging characteristics of cervical artery atherosclerosis and the 10-year risk of ASCVD. Specifically, we wanted to examine how often the ASCVD risk score is concordant or discordant with cervical artery imaging findings.
Methods

Study Population
With the approval of our institutional review board, we retrospectively identified all patients who underwent a cervical CTA at our institution from January 2013 to July 2016, and extracted the clinical information required to calculate the 10-year ASCVD score using the Pooled Cohort Equations referred to in the 2013 ACC/AHA guidelines. Patients were included in the analysis if the 10-year ASCVD score could be calculated (race can be defined, age between 40 and 79 years, total cholesterol between 130 and 320 mg/dL, high-density lipoprotein cholesterol between 20 and 100 mg/dL, and systolic blood pressure between 90 and 200 mmHg). We excluded patients who had carotid or vertebral artery stents or who had undergone endarterectomy, or if there had been longer than 6 months between the clinical visit/blood draw to measure the clinical variables and the imaging. Finally, among those patients included in the study, if a patient underwent several CTAs, we selected for our analysis the CTA data corresponding to the one obtained closest to the clinical visit/blood draw (Fig 1) .
CTA Imaging Protocol
The CTA studies of the carotid arteries were obtained on 16-slice or 64-slice CT scanners. The image acquisition protocol was as follows: spiral mode, .6-.8-second gantry rotation, collimation: 16 or 64 × .5-1.25 mm, pitch around 1:1, slice thickness: 1-1.25 mm, reconstruction interval: .75-1 mm, and acquisition White solid arrow shows calcified plaque, white hollow arrow shows soft plaque; rectangle tail arrow shows arterial lumen.
parameters: 120 kVp/240 mA. A caudo-cranial scanning direction was selected, covering the mid-chest to the vertex of the brain. Seventy to eighty mL of Isovue 300 or 370 (lopamidol; Bracco Diagnostics Inc, Monroe Township, NJ) was injected into an antecubital vein with a power injector at a rate of 4-5 mL per second. Optimal timing of the CTA acquisition was achieved using a test bolus technique. Effective dose associated with this CTA protocol was about 7-10 mSv.
CTA Imaging Review
Carotid arteries were divided into three segments: common carotid arteries, cervical internal carotid arteries, and intracranial internal carotid arteries. Vertebral arteries were divided into three segments: origins and proximal segments, cervical segments and intracranial segments. We formatted images perpendicular to the lumen of each of these segments and visually assessed each segment for: maximal degree of stenosis (using the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria), maximal atherosclerotic plaque thickness, presence of lipid-rich plaque, presence of calcified plaque, and presence of plaque ulceration. 13 A soft plaque was diagnosed when associated with a CT attenuation < 60 Hounsfield units. A calcium plaque was diagnosed when associated with a CT attenuation > 130 Hounsfield units 14 ( Fig 2) . Two neuroradiologists reviewed the CTA studies and characterized the elements listed above. Discrepancies were solved by consensus review.
Statistical Analysis
Patients were divided into two groups based on the 10-year AS-CVD score: <7.5% and ࣙ7.5%. We also tested a more stringent cutoff value and repeated our analysis in patients with 10-year ASCVD score <10% and ࣙ10%.
Demographics, medical history, and imaging characteristics of the cohort were summarized by counts and percentages for categorical characteristics and by median and interquartile range (IQR) for continuous characteristics. Significant differences between the two risk groups were assessed by Fisher's exact test for categorical variables and the MannWhitney U-test or t-tests for continuous variables, depending on whether the distribution was symmetric. All tests were twosided and conducted at the .05 level of significance. As the goal of our study is to characterize the association between 10-year ASCVD score and imaging features, P-values were not adjusted for multiple comparisons. Rather, we utilize the P-values resulting from statistical testing to describe associations. Association between ASCVD scores and imaging features was assessed using Kappa statistics. 15 All analyses were conducted in the R statistical computing framework, version 3.3.
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Results
Study Population
From the 1,405 patients who underwent a cervical CTA between January 2013 and July 2016, 146 patients met our inclusion criteria (Fig 1) . The median time interval between the blood work and CTA was 1 day, with an IQR of -7 to 18 days.
As expected, there were significant differences in all of the variables used to calculate the ASCVD score. Patients with a 10-year ASCVD score ࣙ7.5% were significantly more likely to be male (61, 64.9%), older (68 vs. 51), smokers (17% vs. 3.8%), have a diagnosis of arterial hypertension (68.1% vs. 34.6%) or diabetes (31.9% vs. 13.5%), and/or prescribed cholesterollowering medication (Table 1) . Even more pronounced differences were observed for patients with a 10-year ASCVD score ࣙ10% (Table 2) .
Imaging Findings
Patients with a 10-year ASCVD score ࣙ7.5% had significantly more arterial segments showing stenosis (61, 64.9%) than patients with an ASCVD score <7.5% (52, 35.6%, P < .001), while significant stenosis (>50% [4, 7 .7%] or >75% [3, 5.8%]) was rare in patients with a 10-year ASCVD score<7.5%. Maximal plaque thickness was significantly higher in patients with a 10-year ASCVD score ࣙ7.5% (mean 2.33 vs. .42 mm, P < .001). Soft plaques (52, 55.3% vs. 7, 13.5%, P < .001) and plaques with superficial calcium (78, 83% vs. 9, 17.3% P < .001) were significantly more frequent in patients with a 10-year ASCVD score ࣙ7.5%. Finally, plaques with deep calcium and ulcerated plaques were rare in patients with a 10-year ASCVD score<7.5% (1, 1.9% vs. 12, 12.8%) ( Table 3) . Similar observations were made for patients with a 10-year ASCVD score ࣙ10% (Table 4) .
Congruence between 10-Year ASCVD Score and Imaging Findings
Among the 94 patients with a 10-year ASCVD score ࣙ7.5%, 33 (35.1%) had no arterial stenosis at all, 52 (55.3%) had minimal stenosis less than 50%, 35 (37.2%) had a maximal plaque thickness less than. 9 mm, 42 (44.7%) had no soft plaque, 9 (9.6%) had no calcified plaque, and 82 (87.2%) had no plaque ulceration (Table 3 ). There was a significant overlap between patients showing no arterial stenosis, a maximal plaque thickness less than. 9 mm, and no soft plaque. Only seven of these patients (7.4%) showed no calcium, while most of them (24, or 25.5%) had at least one tiny speck of arterial calcium (Fig 3A) . Among the 52 patients with a 10-year ASCVD score <7.5%, 8 (15.4%) had some arterial stenosis, 8 (15.4%) had a maximal plaque thickness more than. 9 mm, 7 (13.5%) had at least one soft plaque, 15 (28.8%) had at least one calcified plaque, and 1 (1.9%) had one ulcerated plaque (Table 3 ). There was a significant overlap between the patients showing some arterial stenosis, a maximal plaque thickness more than. 9 mm, and at least one soft plaque. Calcified plaques could be observed independently of the other features (Fig 3B) .
Among the 82 patients with a 10-year ASCVD score ࣙ10%, 29 (35.4%) had no arterial stenosis at all, 46 (56.1%) had minimal stenosis less than 50%, 31 (37.8%) had a maximal plaque thickness less than. 9 mm, 37 (45.1%) had no soft plaque, 7 (8.5%) had no calcified plaque, and 72 (87.8%) had no plaque ulceration (Table 4 ). There was a significant overlap between patients showing no arterial stenosis, a maximal plaque thickness less than. 9 mm, and no soft plaque. Only five of these patients (6.1%) showed no calcium, while most of them (22, or 26.8%) had at least one tiny speck of arterial calcium (Fig 3C) .
Amongst the 64 patients with a 10-year ASCVD score <10%, 16 (25.0%) had some arterial stenosis, 16 (25.0%) had a maximal plaque thickness more than. 9 mm, 14 (21.9%) had at least one soft plaque, 25 (39.0%) had at least one calcified plaque, and 3 (4.7%) had at least one ulcerated plaque (Table 4) . There was a substantial overlap between the patients showing some arterial stenosis, a maximal plaque thickness more than. 9 mm, and at least one soft plaque. Calcified plaques could be observed independently of the other features (Fig 3D) . Calcium was mostly present in the carotid arteries and tended to involve multiple arterial segments. It appeared to be a nonspecific marker that was present in patients independently of their 10-year ASCVD score (Tables 3 and 4) .
The imaging characteristics presented moderate or fair agreement with the ASCVD scores based on the Kappa statistics (Tables 3 and 4) .
Discussion
The goal of our study was to determine whether patients with a higher 10-year ASCVD risk score have more advanced imaging features of carotid artery atherosclerosis. The 10-year ASCVD risk score had the best net benefit compared to the modified Framingham risk score. 17 We found that patients with higher 10-year ASCVD risk score overall had more stenosis, thicker artery walls, more soft plaques, and more ulcerations. Calcified plaque was the only imaging feature that was frequently observed in patients with both low and high 10-year ASCVD risk score. On the other hand, we found a substantial fraction of patients with high 10-year ASCVD risk scores who had minimal imaging abnormalities, as well as a significant fraction of patients with low 10-year ASCVD risk scores who nonetheless had imaging abnormalities. For instance, no arterial stenosis was observed in 32 (34.0%) and 28 patients (34.1%) who had 10-year ASCVD risk score ࣙ7.5% and ࣙ10%, respectively. Based on these results, further study is indicated to see if carotid artery imaging can more precisely risk-stratify individual patients, thereby providing improved prognostic information and better informing shared-decision making about initiation of statin therapy.
Our results are consistent with previously published findings examining the role of coronary imaging in enhancing risk stratification. A number of observational studies have documented strong associations between coronary calcium scores and the risk of incident cardiovascular events. [18] [19] [20] There is increasing evidence that coronary calcium scores improve risk classification, particularly for intermediate-risk individuals. Calcium scores reclassified 36% of intermediaterisk individuals, including 23% who were upclassified to high risk. 21 Another established technology for assessing subclinical atherosclerosis is carotid ultrasound, which could potentially be more effective than CAC for refining stroke risk prediction. Clinical studies have focused in particular on carotid intimamedia thickness (IMT), the combined thickness of the intimal and medial layers of the carotid artery, which is typically measured at the far wall of the common or internal carotid arteries. Because elevated IMT probably predates atherosclerotic plaque, it can be viewed as an earlier biomarker of subclinical atherosclerosis than coronary calcium. 22 Multiple epidemiological studies have examined the association of carotid IMT with cardiovascular risk. 23 One study found the carotid plaque burden and maximum carotid plaque thickness to be associated with ASCVD, but not the IMT. 24 In our study, we focused on the CTA-based carotid wall thickness instead of the IMT. The IMT on carotid ultrasound and the carotid artery wall thickness on carotid CTA have been demonstrated to be in agreement with each other. 25 The maximal wall thickness as measured on CTA was shown to predict subsequent new carotid stroke. 26 Carotid CTA can not only detect luminal stenosis, but also characterize atherosclerotic plaque features. Whether carotid CTA could improve the stratification of the ASCVD risk score merits investigation by future research studies.
We acknowledge several limitations to our study. It is retrospective and cross-sectional in nature. The blood work and the carotid imaging were not obtained at the exact same time but within 6 months of each other. CT-angiograms of the cervical arteries of the patients enrolled in the study were ordered as part of routine standard of care, which suggests that their vascular risk might be higher than that of the general population. This might result in the 10-year ASCVD risk scores observed in our sample being higher than in the general population; however, this should not affect the comparison between 10-year ASCVD risk score and imaging. We did not compare directly CTA with other imaging modalities and related features, such as carotid ultrasound and IMT.
In conclusion, our study determined that there is some association but not a perfect overlap between 10-year ASCVD risk scores calculated from clinical and blood assessment, and the imaging features of cervical atherosclerotic disease. Our next step will be to determine the incidence of vascular events in
